JCEM1 Best of JCEM 2015 Part 1

Program: Special Scientific Session
Clinical Session
Sunday, April 3, 2016: 12:45 PM-2:45 PM
Room 107 (BCEC)
Chair:
R. Paul Robertson, MD, Univ of Washington, Seattle, WA

Nothing to Disclose: RPR

12:50 PM
Samar R. El Khoudary, PhD, MPH, FAHA, Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA
Nothing to Disclose: SRE
1:10 PM
Pia Burman, MD, PhD, Department of Endocrinology, Skane University Hospital, Malmö, University of Lund, Malmo, Sweden
Nothing to Disclose: PB
1:30 PM
Jens Bollerslev, MD, DMSC, Section of Specialized Endocrinology, Oslo University Hospital-Rikshospitalet, Oslo, Norway
Nothing to Disclose: JB
1:50 PM
Terry P. Combs, PhD, Division of Endocrinology, Department of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC
Nothing to Disclose: TPC
2:10 PM
Márta Korbonits, MD, PhD, Centre for Endocrinology, Barts and The London School of Medicine, London, United Kingdom
Disclosures:
MK: Advisory Group Member, Pfizer, Inc., Investigator, Pfizer, Inc., Investigator, Novartis Pharmaceuticals, Advisory Group Member, AeternaZentaris.

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire